As of March 2026 Adaptive Biotechnologies has a market cap of NZ$3.32 Billion. This makes Adaptive Biotechnologies the world's 4738th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 27th, 2026 the market cap of Adaptive Biotechnologies was reported to be: